OASMIA PHARMACE/ADR (NASDAQ:OASM) Stock Price Down 2.4%

Share on StockTwits

OASMIA PHARMACE/ADR (NASDAQ:OASM) dropped 2.4% during trading on Monday . The company traded as low as $1.60 and last traded at $1.60. Approximately 4,007 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 98,414 shares. The stock had previously closed at $1.64.

The business has a 50 day simple moving average of $1.75 and a 200-day simple moving average of $1.74.

OASMIA PHARMACE/ADR Company Profile (NASDAQ:OASM)

Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations and drug-delivery systems based on cytostatics. The company's approved products include Paclical/Apealea, a water-soluble formulation of XR17 and paclitaxel to treat cancers, such as lung, breast, and ovarian cancer; and Paccal Vet, a formulation for the treatment of squamous cell carcinoma and mammary carcinoma in dogs.

Read More: What is Cost of Debt?

Receive News & Ratings for OASMIA PHARMACE/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OASMIA PHARMACE/ADR and related companies with MarketBeat.com's FREE daily email newsletter.